Hong Kong new listing regime for emerging and innovative companies

Start adding items to your reading lists:
or
Save this item to:
This item has been saved to your reading list.
Apr 2018

On 24 April 2018, the Stock Exchange of Hong Kong Limited reached a conclusion on the Main Board listing requirements for:

(a)    pre-revenue/pre-profit biotech companies

(b)    innovative companies with weighted voting right structures, and

(c)    innovative companies seeking a secondary listing in Hong Kong.

The requirements came into effect on 30 April 2018. Companies may submit a formal application for listing under the new regime on or after 30 April 2018.

Contact us

Kennedy Liu
Head of Capital Markets and Accounting Advisory Services , PwC Hong Kong
Tel: +[852] 2289 1881
Email

Edmond Chan
Capital Markets Services Co-Head, PwC Hong Kong
Tel: +[852] 2289 1128
Email

Eddie Wong
Partner, PwC Hong Kong
Tel: +[852] 2289 2896
Email

Pauline Leung
Partner, PwC Hong Kong
Tel: +[852] 2289 1809
Email

Follow us